2020 ISPE Virtual Biopharmeceutical Manufacturing Conference & Workshop - June 1-4, 2020

    Event Date
    Add to Calendar 2020 ISPE Virtual Biopharmeceutical Manufacturing Conference & Workshop - June 1-4, 2020     ISPE-CaSA Members use promo code SAVE15% when registering by 18 May to save 15% on the combined conference and workshop registration.   2020 ISPE Biopharmaceutical Manufacturing Virtual Conference [ispe.org], taking place 1–2 June 2020 2020 ISPE Continuous Manufacturing Virtual Workshop [ispe.org], taking place 3–4 June 2020. What Can You Expect? Fully Loaded Agendas: Between the two events, you'll benefit from topic-focused presentations and panel discussions from 80+ global experts representing FDA, GSK, Kite Pharma, Merck, NIIMBL, Novartis, Roche, Sanofi, and more. Ease of Experience: The event portal is easy to navigate and will allow you to view presentations, participate in Q&A sessions with speakers, plus network and knowledge share with your fellow attendees. The 2020 ISPE Biopharmaceutical Manufacturing Virtual Conference will also feature a virtual exhibitor experience. BONUS: You will receive access to the recording of all conference and workshop sessions for one year. Actionable Insights: Hear from global experts as they share their knowledge and lessons learned on advanced therapeutic medicinal products (ATMPs) such as cell and gene therapies, digitalization, single-use technology, implications of ICH Q12 for biopharma, and much more. Conference Featured Speakers: Wilson Bryan, MD Director, Office of Tissues and Advanced Therapies, FDA/CBER Patricia Hughes, PhD, Branch Chief, Division of Microbiology Assessment, FDA/CDER Lawrence Hill, PharmD, MBA, CEO, Gan & Lee Pharmaceuticals USA Corp. Carol Lynch, President, US and Head North America, Sandoz US Inc. Maria Hoffman, Executive Director, Engineering, Merck & Co Inc. Niranjan Kulkarni, PhD, Director, Operations Improvement, CRB And More Workshop Featured Speakers: Rapti Madurawe, PhD, Director, Division of Process Assessment I, FDA/CDER/OPQ Stelios Tsinontides, Director, Office of Pharmaceutical Assessment, FDA Moiz Diwan, PhD, Director, Pharmaceutical Development Research & Development, AbbVie John Erickson, PhD, Senior Fellow, NIIMBL And More We genuinely believe you will find the 2020 ISPE Biopharmaceutical Manufacturing Virtual Conference [ispe.org] and the 2020 ISPE Continuous Manufacturing Virtual Workshop [ispe.org] to be more beneficial now than ever before and will provide you with solutions to critical challenges and information on possible changing of industry norms.  To explore the complete education agendas and to register, please visit ISPE.org/Bio20 [ispe.org] and ISPE.org/ContinuousWrksp [ispe.org]. Support your attendance with a justification letter.   Virtual . ., United States rcisneros@rickzebradesigns.com America/New_York public
    Program Information

    ISPE Virtual Conf June 1-3

     

     

    ISPE-CaSA Members use promo code SAVE15% when registering by 18 May to save 15% on the combined conference and workshop registration.

     

    2020 ISPE Biopharmaceutical Manufacturing Virtual Conference [ispe.org], taking place 1–2 June 2020

    2020 ISPE Continuous Manufacturing Virtual Workshop [ispe.org], taking place 3–4 June 2020.

    What Can You Expect?

    • Fully Loaded Agendas: Between the two events, you'll benefit from topic-focused presentations and panel discussions from 80+ global experts representing FDA, GSK, Kite Pharma, Merck, NIIMBL, Novartis, Roche, Sanofi, and more.
    • Ease of Experience: The event portal is easy to navigate and will allow you to view presentations, participate in Q&A sessions with speakers, plus network and knowledge share with your fellow attendees. The 2020 ISPE Biopharmaceutical Manufacturing Virtual Conference will also feature a virtual exhibitor experience. BONUS: You will receive access to the recording of all conference and workshop sessions for one year.
    • Actionable Insights: Hear from global experts as they share their knowledge and lessons learned on advanced therapeutic medicinal products (ATMPs) such as cell and gene therapies, digitalization, single-use technology, implications of ICH Q12 for biopharma, and much more.


    Conference Featured Speakers:

    • Wilson Bryan, MD Director, Office of Tissues and Advanced Therapies, FDA/CBER
    • Patricia Hughes, PhD, Branch Chief, Division of Microbiology Assessment, FDA/CDER
    • Lawrence Hill, PharmD, MBA, CEO, Gan & Lee Pharmaceuticals USA Corp.
    • Carol Lynch, President, US and Head North America, Sandoz US Inc.
    • Maria Hoffman, Executive Director, Engineering, Merck & Co Inc.
    • Niranjan Kulkarni, PhD, Director, Operations Improvement, CRB
    • And More


    Workshop Featured Speakers:

    • Rapti Madurawe, PhD, Director, Division of Process Assessment I, FDA/CDER/OPQ
    • Stelios Tsinontides, Director, Office of Pharmaceutical Assessment, FDA
    • Moiz Diwan, PhD, Director, Pharmaceutical Development Research & Development, AbbVie
    • John Erickson, PhD, Senior Fellow, NIIMBL
    • And More

    We genuinely believe you will find the 2020 ISPE Biopharmaceutical Manufacturing Virtual Conference [ispe.org] and the 2020 ISPE Continuous Manufacturing Virtual Workshop [ispe.org] to be more beneficial now than ever before and will provide you with solutions to critical challenges and information on possible changing of industry norms. 

    To explore the complete education agendas and to register, please visit ISPE.org/Bio20 [ispe.org] and ISPE.org/ContinuousWrksp [ispe.org].

    Support your attendance with a justification letter.